Drug-induced changes in cardiac energy.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D002415:Cats; D002463:Cell Membrane Permeability / Q000187:drug effects; D003035:Cobalt / Q000494:pharmacology; D003998:Dicarboxylic Acids / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009532:Nickel / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects*; D011299:Prenylamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D011817:Rabbits; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014700:Verapamil / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D003035:Cobalt; D009532:Nickel; D012964:Sodium; D014700:Verapamil; D011299:Prenylamine; D007545:Isoproterenol; D002118:Calcium; D004837:Epinephrine